Firm & fund profile / Sourced portfolio
Mubadala
Tracked participation in 4 Atlas companies, with 0 explicitly attributed leads.
4portfolio companies
5round participations
0lead positions
Invalid Datelatest activity
Capital activity
Portfolio
CompanyLatest valuationFirst → latestRoundsRoleLatest round
IT
Iambic Therapeutics—Nov 2025 → Nov 20251 roundParticipantOversubscribed financing (round size disclosed as “over $100 million”)